Ultragenyx Grants 36,447 RSUs to 12 New Non-Executive Officers

Ultragenyx Pharmaceutical Inc. granted 36,447 restricted stock units (RSUs) to 12 newly hired non-executive officers on April 16, 2026. These awards were approved by the compensation committee under the Ultragenyx Employment Inducement Plan, serving as an inducement for the new employees to join the company. The RSUs will vest over four years, with 25% vesting on each anniversary of the grant date, contingent on continuous employment.